CMS releases 3Q ASP drug pricing, several codes removed

Why This Topic Matters

ASP list updates can affect how payers, providers, and coders monitor drug pricing changes and code status from one quarter to the next. This article helps readers understand which Medicare Part B drug codes changed, which were discontinued from the quarterly list, and the overall direction of pricing movement.

Article Sections

1. Overview of Q3 ASP drug pricing changes

   Summarizes the overall direction of Medicare Part B drug price movement for the quarter and notes the general pattern of additions and removals.

2. Notable price increases and new additions

   Highlights selected drugs with the largest reported price increases and identifies newly added codes on the quarterly ASP list.

3. Codes removed from the ASP list

   Lists the drug codes removed from the quarterly ASP pricing file and notes the article’s discussion of code status impact.

4. Key ASP changes for the third quarter (Q3) of 2011

   Presents the article’s summarized table of selected quarterly ASP price increases and decreases.

5. Increases

   Identifies selected drug codes that showed quarter-to-quarter price increases in the summary table.

6. Decreases

   Identifies selected drug codes that showed quarter-to-quarter price decreases in the summary table.